News APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) Staff September 11, 2023 Post Views: 42 Related Continue Reading Previous Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of DirectorsNext Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse More Stories Brain Cancer Clinical Trial Healthcare News Pharmaceutical AlzeCure gets Presentation Accepted on Disease-Modifying Effects of ACD856 at Alzheimer’s Conference Staff September 26, 2023 Healthcare News FendX Engages Independent Trading Group (ITG), Inc. for Market Making Services and Engages Longtable Capital Partners for IR Services Staff September 25, 2023 Concussion EHR Healthcare News Patient Care NextGen Healthcare Supports Athletico Physical Therapy’s Growing Footprint Staff September 25, 2023
